Delivery Order SPE2DB22D3501-SPE2DB24FUU17

Award Date 3/1/24
Potential Completion Date 3/4/24
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,732.21, is a firm fixed price delivery order for 4563154586 VRAYLAR 1.5 MG CAPSULE 30S. The contract has an ultimate completion date of December 21, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $20,401.49 and has a completion date of December 10, 2024. It is a firm fixed-price contract for the delivery of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,017.28, is a Firm Fixed Price Delivery Order for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of February 18, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,002.86, is a delivery order with a firm fixed price for the supply of VRAYLAR 1.5 MG CAPSULE 30S to support military healthcare programs. The contract has an ultimate completion date of February 25, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,731.86 firm fixed-price delivery order is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a medication. The contract has an ultimate completion date of February 2, 2024. Amerisourcebergen has a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $37,085.15, is for the delivery of VRAYLAR 1.5 MG CAPSULE 30S, a prescription medication. The contract has a firm fixed price structure and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,033.29 Firm Fixed Price Delivery Order contract is for the provision of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of November 15, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,810.78, is for the delivery of VRAYLAR 3 MG CAPSULES. The contract is a Firm Fixed Price Delivery Order with a completion date of January 9, 2025. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of VRAYLAR 1.5 MG CAPSULE 30S. The $6,622.44 Firm Fixed Price contract has a completion date of September 26, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999 through December 2025, which serves as the primary vehicle for providing a wide range of...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,736.05 fixed-price delivery order is for the supply of VRAYLAR 6 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of January 24, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FUU17
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,793.62, is for the provision of VRAYLAR 1.5 MG CAPSULE 30S, a branded pharmaceutical product. The contract has an ultimate completion date of March 4, 2024 and is a firm fixed price arrangement.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/14/25, 9:44 AM